Mednet Logo

Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?

3 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network
Answered on

It doesn’t change the decisions for APBI with all other factors being favorable.

We offer APBI to invasive lobular also if it meets all criteria and had MRI breast done as part of the evaluation.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Washington University School of Medicine
Answered on

I admit that it does, although this is a data-free zone! Associated LCIS is allowed by consensus statement criteria, but if the bed-to-breast size ratio is suboptimal, I often just do ultrahypofractionated whole breast instead.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Hôtel Dieu de Lévis - CISSS Chaudière-Appalaches
Answered on

Most probably, it wouldn't change the outcomes if it's a classic LCIS.

If it's a pleomorphic LCIS, it should be considered as a DCIS, and many argue that it's akin to a high-grade DCIS, with a high likelihood of hormone-receptor negative status, and sometimes with necrosis. Margins >2 mm are desired...

Join for free or sign in to see the full answer